<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03338270</url>
  </required_header>
  <id_info>
    <org_study_id>Neuroradiology Karolinska Uni.</org_study_id>
    <nct_id>NCT03338270</nct_id>
  </id_info>
  <brief_title>Clinical Validation Study of Multi-EPI Mix</brief_title>
  <official_title>Clinical Validation Study of a Novel Minute MRI Sequence</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Karolinska University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>GE Healthcare</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Karolinska University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study aims to assess the diagnostic validity of a new minute-MRI sequence for
      neuroradiological evaluation in comparison to conventional MRI.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The study aims to assess the imaging quality with regards to artefacts and lesion conspicuity
      as well as its diagnostic potential in rendering a probable diagnosis. The primary study aim
      is to define the AUC for diagnostic performance of minute MRI compared to conventional MRI.

      Included patients are those with suspiscion of cerebral pathology.

      Study participancts are investigated at 3T.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">December 1, 2017</start_date>
  <completion_date type="Anticipated">October 2018</completion_date>
  <primary_completion_date type="Anticipated">March 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Diagnostic potential</measure>
    <time_frame>At MRI scan. Diagnostic accuracy to categorize scan as normal or abnormal on a five point Likert scale compared to abnormal/normal conventional MRI.</time_frame>
    <description>Diagnostic performance of lesion conspicuity of new MR sequence compared to conventional sequences</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Lesion location determination</measure>
    <time_frame>At MRI scan</time_frame>
    <description>Anatomical localization of abnormality</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Lesion classification</measure>
    <time_frame>At MRI scan</time_frame>
    <description>Classification into disease categories</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Imaging quality</measure>
    <time_frame>At MRI scan</time_frame>
    <description>Artefacts</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Diagnostic imaging quality</measure>
    <time_frame>At MRI scan</time_frame>
    <description>Diagnostic imaging quality</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Anatomical conspicuity</measure>
    <time_frame>At MRI scan</time_frame>
    <description>Specified anatomical structures</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Multifocality</measure>
    <time_frame>At MRI scan</time_frame>
    <description>Determine multifocal lesion</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Ability to rule out diseases</measure>
    <time_frame>At MRI scan</time_frame>
    <description>A list of diseases</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Lesion description</measure>
    <time_frame>At MRI scan</time_frame>
    <description>For example effect on brain parenchyma and size</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Diagnostic confidence</measure>
    <time_frame>At MRI scan</time_frame>
    <description>Scale</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Brain coverage</measure>
    <time_frame>At MRI scan</time_frame>
    <description>Full or lower</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Clinical diagnostic summay report</measure>
    <time_frame>At MRI scan</time_frame>
    <description>Text</description>
  </secondary_outcome>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Brain Diseases</condition>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>MRI</intervention_name>
    <description>MRI sequence without intravenous contrast</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Neuroradiological indication for brain MRI
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

        - Neuroradiological MRI

        Exclusion Criteria:

        - Aborted exam
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Anna Falk Delgado, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Clinical Neuroscience</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Anna Falk Delgado, MD, PhD</last_name>
    <phone>0046725474204</phone>
    <email>anna.falk-delgado@sll.se</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Anna Falk Delgado</last_name>
    <phone>0046725474204</phone>
    <phone_ext>+46</phone_ext>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Karolinska University Hospital</name>
      <address>
        <city>Stockholm</city>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Anna Falk Delgado, MD, PhD</last_name>
    </contact>
  </location>
  <location_countries>
    <country>Sweden</country>
  </location_countries>
  <verification_date>November 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 7, 2017</study_first_submitted>
  <study_first_submitted_qc>November 7, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">November 9, 2017</study_first_posted>
  <last_update_submitted>December 17, 2017</last_update_submitted>
  <last_update_submitted_qc>December 17, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">December 19, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Karolinska University Hospital</investigator_affiliation>
    <investigator_full_name>Anna Falk Delgado</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>MRI</keyword>
  <keyword>Neuroradiology</keyword>
  <keyword>minute-MRI</keyword>
  <keyword>multi EPI-mix</keyword>
  <keyword>Clinical Validation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Brain Diseases</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

